News
Zeiss Medical Technology announced today that it received CE mark approval for its Cirrus PathFinder clinical support tool.
Method AI announced today that it raised $20 million in Series A funding to support its novel surgical ultrasound platform. The Boston-based company, co-founded by former Corindus COO Doug Teany, who ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results